| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5701787 | Journal of Thoracic Oncology | 2016 | 45 Pages | 
Abstract
												PD-L1 protein expression was significantly higher in smoking-associated adenocarcinoma and in EGFR mutation-negative adenocarcinoma. PD-L1 protein expression was associated with poor survival in patients with lung adenocarcinoma. The PD-L1/programmed cell death 1 pathway may contribute to the progression of smoking-associated tumors in lung adenocarcinoma.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Oncology
												
											Authors
												Kazuki MD, Tatsuro MD, PhD, Fumihiro MD, PhD, Mototsugu PhD, Takaki MD, Shinkichi MD, Masakazu MD, Yuzo MD, Takatoshi MD, Gouji MD, PhD, Yosuke MD, PhD, Shinji MD, PhD, Yoshinao MD, PhD, Yoshihiko MD, PhD, 
											